Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/78906
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | White, D. | - |
dc.contributor.author | Eadie, L. | - |
dc.contributor.author | Saunders, V. | - |
dc.contributor.author | Hiwase, D. | - |
dc.contributor.author | Hughes, T. | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Leukemia, 2013; 27(5):1201-1204 | - |
dc.identifier.issn | 0887-6924 | - |
dc.identifier.issn | 1476-5551 | - |
dc.identifier.uri | http://hdl.handle.net/2440/78906 | - |
dc.description.statementofresponsibility | DL White, LN Eadie, VA Saunders, DK Hiwase, and TP Hughes | - |
dc.language.iso | en | - |
dc.publisher | Nature Publishing Group | - |
dc.rights | © 2013 Macmillan Publishers Limited | - |
dc.source.uri | http://dx.doi.org/10.1038/leu.2012.295 | - |
dc.subject | K562 Cells | - |
dc.subject | Humans | - |
dc.subject | Benzamides | - |
dc.subject | Piperazines | - |
dc.subject | Pyrimidines | - |
dc.subject | Protein Kinase Inhibitors | - |
dc.subject | Drug Interactions | - |
dc.subject | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | - |
dc.subject | Proton Pump Inhibitors | - |
dc.subject | Imatinib Mesylate | - |
dc.title | Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1038/leu.2012.295 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | White, D. [0000-0003-4844-333X] | - |
dc.identifier.orcid | Eadie, L. [0000-0003-1912-7602] | - |
dc.identifier.orcid | Hiwase, D. [0000-0002-6666-3056] | - |
dc.identifier.orcid | Hughes, T. [0000-0002-0910-3730] [0000-0002-7990-4509] | - |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.